| Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling P ten Dijke, C Krause, DJJ De Gorter, CWGM Löwik, RL Van Bezooijen JBJS 90 (Supplement_1), 31-35, 2008 | 267 | 2008 |
| Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways C Krause, O Korchynskyi, K de Rooij, SE Weidauer, DJJ de Gorter, ... Journal of Biological Chemistry 285 (53), 41614-41626, 2010 | 215 | 2010 |
| Noggin C Krause, A Guzman, P Knaus The international journal of biochemistry & cell biology 43 (4), 478-481, 2011 | 195 | 2011 |
| Identification of a key residue mediating bone morphogenetic protein (BMP)-6 resistance to noggin inhibition allows for engineered BMPs with superior agonist activity K Song, C Krause, S Shi, M Patterson, R Suto, L Grgurevic, S Vukicevic, ... Journal of Biological Chemistry 285 (16), 12169-12180, 2010 | 160 | 2010 |
| Elevated transforming growth factor β and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts C Krause, P Kloen, P Ten Dijke Fibrogenesis & tissue repair 4, 1-15, 2011 | 79 | 2011 |
| RGK small GTP-binding proteins interact with the nucleotide kinase domain of Ca2+-channel β-subunits via an uncommon effector binding domain P Béguin, YJA Ng, C Krause, RN Mahalakshmi, MY Ng, W Hunziker Journal of Biological Chemistry 282 (15), 11509-11520, 2007 | 79 | 2007 |
| Signal transduction cascades controlling osteoblast differentiation C Krause, DJJ de Gorter, M Karperien, P ten Dijke Primer on the metabolic bone diseases and disorders of mineral metabolism 7 …, 2008 | 73 | 2008 |
| Comprehensive analysis of TGF-β and BMP receptor interactomes MP Belverdi, C Krause, A Guzman, P Knaus European Journal of Cell Biology 91 (4), 287-293, 2012 | 13 | 2012 |
| Concurrent inhibition of TGF-β and mitogen driven signaling cascades in Dupuytren’s disease–Non-surgical treatment strategies from a signaling point of view C Krause, P Kloen Medical hypotheses 78 (3), 385-388, 2012 | 13 | 2012 |
| Control of bone mass by sclerostin: Inhibiting BMP-and WNT-induced bone formation DJJ de Gorter, C Krause, P ten Dijke, CWGM Löwik, RL van Bezooijen Bone Morphogenetic Proteins: From Local to Systemic Therapeutics, 257-276, 2008 | 7 | 2008 |
| The imperative balance of agonist and antagonist for BMP signalling driven adult tissue homeostasis C Krause Austin Biomark Diagn 1 (2), 2014 | 4 | 2014 |
| Action-based analysis of discrete regulatory networks with short-term stimuli C Krause, C Krause, EP de Vink Proceedings of the 8th International Conference on Computational Methods in …, 2010 | 3 | 2010 |
| Wnt-Signalwege im Knochenstoffwechsel M Peterlik Osteologie 20 (03), 197-202, 2011 | 2 | 2011 |
| Lö wik CW, van Bezooijen RL. 2008. Osteocyte-derived sclerostin inhibits bone formation: Its role in bone morphogenetic protein and Wnt signaling P ten Dijke, C Krause, DJ de Gorter J Bone Joint Surg Am 90, 31-35, 0 | 2 | |
| Modeling of the BMP mediated co-regulation of the Smad and Non-Smad pathways in the context of cell density P Gupta, C Krause, P Rikeit, S Röblitz, P Knaus, C Schütte 10th International BMP conference, 2014, Berlin, Germany, 2014 | | 2014 |
| Mathematical modeling of the Smad and Non-Smad BMP signaling pathways in context of cell density P Gupta, S Röblitz, C Krause, P Knaus, C Schütte | | 2013 |
| Inhibition of signaling cascades in osteoblast differentiation and fibrosis C Krause Int J Biochem Cell Biol 43 (4), 478-81, 2011 | | 2011 |
| Elevated TGF-β and MAP kinase pathways mediate fibrotic traits of Dupuytren’s disease fibroblasts C Krause, P Kloen, P ten Dijke | | |
Peter ten DijkeLeiden University Medical Center and Oncode InstituteDirección de correo verificada de lumc.nl